The man alleged the asbestos in J&J’s talc-based products, including its baby powder, caused him to develop the cancer that has been linked to asbestos exposure.
J&J is facing about 13,000 talc-related lawsuits nationwide. The drugmaker denies that its talc causes cancer, arguing tests revealed its talc is safe and asbestos-free.
More articles on pharmacy:
10 hospitals seeking pharmacy leadership
Patent protection clause is latest stumbling block for revised NAFTA
Dr. Reddy’s legal win expected to lower cost of opioid addiction treatment
J&J said the ruling underscores the safety of its baby powder.
Read the full report here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
